| Q1 2021 | From Incorporation to November 2020 | % Change |
| Total revenues | $6,880,325 | $581,643 | 1,083% |
| Net loss | $4,892,781 | $1,040,231 | 370% |
| Loss per share - basic | $0.03 | $0.03 | 0% |
| EBITDA | ($4,819,777) | ($994,462) | 385% |
The following reconciles the net income, EBITDA and Adjusted EBITDA (non IFRS):
| | Q1 2021 | Q3 &Q4 2020 |
| | March 31, 2021 | |
| Net loss | $4,892,781 | $1,040,231 |
| Add: income tax provisions (recovery) | $0.00 | $0.00 |
| Add: depreciation & amortization | $73,004 | $45,769 |
| EBITDA (non IFRS) | ($4,819,777) | ($994,462) |
| Add: share based compensation | - | $548,500 |
| Add: one time listing fees and expenses | $3,155,025 | - |
| Adjusted EBITDA (non IFRS) | ($1,664,752) | ($445,962) |
| | Q1 2021 | Q3 &Q4 2020 | Dollar Change | Percent Change |
| Total Assets | $6,673,936 | $1,702,088 | $4,971,848 | 292% |
| Total Liabilities | $2,304,398 | $807,627 | $1,496,768 | 185% |
Please refer to the note at the end of this news release concerning non-IFRS financial measures.
Q1 Highlights and Subsequent Events
- The Company's revenue reached $6,880,325 in Q1 2021.
- The Company completed its acquisition of 100% of GoStop is a COVID-19 digital reporting passport developed with a privacy preserving approach that will enable people to use the alerting software and downloadable software with authentication certificates.
- The Company received orders for an additional 3 Film & TV productions, 1 in Toronto and 2 in Vancouver. The Company provided services to 22 production companies, 7 in Toronto and 15 in Vancouver.
- The Company announced that it has commenced a new business line providing rapid antigen testing for individuals and corporations with its newly approved Health Canada Rapid Antigen tests.
- The Company announced that it had partnered with a large streaming service company in the world.
- The Company announce that it has opened its first COVID-19 testing clinic in partnership with Concierge Medical Consultants, Inc. located in Coal Harbor, Vancouver.
Outlook
The Company announced that it has entered into a Letter of Intent on May 11, 2021, to acquire the assets of CENTRED Ventures, LLC., a US based travel wellness medical technology company.
Centred connects travelers to leading and emerging wellness brands in over 200 cities worldwide, utilizing a vertically integrated platform with an app, website, physical locations, e-commerce, health and wellness, and loyalty programs. In addition to this, Centred has established relationships with the airport authorities in the UAE where all travelers to the region will be sent the Centred App to upload their proof of a negative Covid-19 test before boarding the flight. ScreenPro sees tremendous opportunities to cross sell its covid tests and services to the over 200 cities that Centred has relationships with.
The Company continues to attract business from the film & tv productions with feature-length movies, episodic series productions, and pilot season quickly ramping up in Toronto and Vancouver, and with multiple mutant variants, the Company will continue expanding the COVID-19 screening business.
About ScreenPro
ScreenPro is a Screening and Medical Technology company. ScreenPro provides turnkey screening solutions with alerting software, GoStop. ScreenPro's unique access to multiple manufacturers of high quality test kits and its strategic partnership with Labs in Vancouver and Ontario allows ScreenPro to be a nationwide provider of a full-service testing solutions across Canada. In addition, ScreenPro has its own nursing professionals, and access to high quality PPEs to ensure that its clients are protected in all aspects of their testing needs. GoStop's passport was developed with a privacy preserving approach that will enable individuals to use the alerting software and downloadable app with authentication certificates. The alerts can be scheduled on an on-demand, daily, weekly, or monthly basis and can be used also for vaccine scheduling.
For additional information on ScreenPro and other corporate information, please visit the Company's website at www.screenprosecurity.com
Neither the Canadian Securities Exchange (the "CSE") nor it's Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
For further information please contact:
Jamie Hyland, Director
Email: info@screenprosecurity.com
P. (604) 442-2425
Forward Looking Statements:
Certain statements contained in this news release may constitute forwardlooking information, including statements relating to expectations regarding the future development of ScreenPro's business. Forwardlooking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forwardlooking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forwardlooking information. The actual results of ScreenPro could differ materially from those anticipated in this forwardlooking information as a result of regulatory decisions, competitive factors in the industries in which ScreenPro operates, prevailing economic conditions, changes to ScreenPro's strategic growth plans, and other factors, many of which are beyond the control of ScreenPro. Management of ScreenPro believes that the expectations reflected in the forwardlooking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forwardlooking information should not be unduly relied upon. Any forwardlooking information contained in this news release represents ScreenPro's expectations as of the date hereof and is subject to change after such date. ScreenPro disclaims any intention or obligation to update or revise any forwardlooking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.
###
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/85766
